Insulin aspart, recombinant Subcutaneous and Latanoprost and Timolol
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Latanoprost and Timolol and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: latanoprost / timolol ophthalmic
Brand name: Baciguent, Probiotic Formula, Proferrin-ES
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Latanoprost Eye Drops (Emulsion)
- Insulin aspart, recombinant Subcutaneous-Latanoprost Eye Drops (Solution)
- Insulin aspart, recombinant Subcutaneous-Latanoprost ophthalmic
- Insulin aspart, recombinant Subcutaneous-Latanoprost Ophthalmic Solution
- Insulin aspart, recombinant Subcutaneous-Latanoprostene Bunod
- Insulin aspart, recombinant Subcutaneous-Latanoprostene bunod ophthalmic
- Latanoprost and Timolol-Insulin degludec
- Latanoprost and Timolol-Insulin Degludec (U-100) Prefilled Pens
- Latanoprost and Timolol-Insulin Degludec (U-100) Vials
- Latanoprost and Timolol-Insulin Degludec (U-200) Prefilled Pens
- Latanoprost and Timolol-Insulin degludec and liraglutide
- Latanoprost and Timolol-Insulin degludec and liraglutide Subcutaneous